Arix Bioscience Holdings Ltd, 10% Owner at LogicBio Therapeutics, Inc. (LOGC), sold 1,168,320 shares at $7.08 ($9.0M) on 2020-09-25, disclosed to the SEC on 2020-10-05.
Open-market sale of $9.0M LOGC by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.56 | 16,332 | $140K | 1.6% |
| 2 | $8.56 | 16,332 | $140K | 1.6% |
| 3 | $9.24 | 31,101 | $287K | 3.2% |
| 4 | $9.24 | 31,101 | $287K | 3.2% |
| 5 | $9.25 | 36,983 | $342K | 3.8% |
| 6 | $9.25 | 36,983 |
| $342K |
| 3.8% |
| 7 | $9.00 | 22,651 | $204K | 2.3% |
| 8 | $8.78 | 2,709 | $24K | 0.3% |
| 9 | $8.79 | 1,335 | $12K | 0.1% |
| 10 | $8.75 | 159 | $1K | 0.0% |
| 11 | $7.63 | 38,514 | $294K | 3.3% |
| 12 | $7.63 | 38,514 | $294K | 3.3% |
| 13 | $7.08 | 174,219 | $1.2M | 13.8% |
| 14 | $7.08 | 174,219 | $1.2M | 13.8% |
| 15 | $7.54 | 273,584 | $2.1M | 23.0% |
| 16 | $7.54 | 273,584 | $2.1M | 23.0% |
| Total | $7.67 avg | 1,168,320 | $9.0M | 100% |